Top compounds associated with response to NRDC


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.016 0.7
mRNA Bortezomib CTRPv2 pan-cancer AAC -0.016 0.7
mRNA UNC0321 CTRPv2 pan-cancer AAC 0.016 0.7
mRNA WAY-362450 CTRPv2 pan-cancer AAC -0.017 0.7
mRNA BRD-K99584050 CTRPv2 pan-cancer AAC -0.023 0.7
mRNA Fumonisin B1 CTRPv2 pan-cancer AAC 0.016 0.7
mRNA KU-0063794 CTRPv2 pan-cancer AAC -0.016 0.7
mRNA WZ3105 GDSC1000 pan-cancer AAC -0.013 0.7
mRNA fingolimod CTRPv2 pan-cancer AAC -0.016 0.7
mRNA Vorinostat gCSI pan-cancer AAC -0.024 0.7
Download CSV